Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
REGNPB Ratio: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
|||
Price-to-book ratio
Latest
2.62
↓ 57% below average
Average (9y)
6.03
Historical baseline
Range
High:17.12
Low:2.62
CAGR
-18.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.62 | -27.4% |
| 2023 | 3.61 | +5.8% |
| 2022 | 3.41 | -4.1% |
| 2021 | 3.56 | -24.6% |
| 2020 | 4.71 | +27.5% |
| 2019 | 3.70 | -24.5% |
| 2018 | 4.90 | -31.0% |
| 2017 | 7.09 | -26.1% |
| 2016 | 9.59 | -44.0% |
| 2015 | 17.12 | - |